You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
可孚醫療(301087.SZ):註冊資本2000萬元設立全資子公司深圳可孚
格隆匯 12-29 20:20

格隆匯12月29日丨可孚醫療(301087.SZ)公佈,根據公司發展戰略,為了進一步完善公司業務佈局,提升公司競爭力,公司設立全資子公司深圳可孚生物科技有限公司(以下簡稱“深圳可孚”),於2021年12月28日取得深圳市市場監督管理局下發的營業執照。

註冊資本:2000萬元人民幣;經營範圍:生物基材料製造;生物基材料銷售;生物基材料技術研發;醫學研究和試驗發展;技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;第一類醫療器械銷售;個人衞生用品銷售;化粧品批發;化粧品零售;實驗分析儀器製造;健康諮詢服務(不含診療服務);國內貿易代理;電子產品銷售;電子元器件製造;電子元器件批發;消毒劑銷售(不含危險化學品)。(除依法須經批准的項目外,憑營業執照依法自主開展經營活動)第二類醫療器械生產;第三類醫療器械生產;第三類醫療器械經營;藥品互聯網信息服務;用於傳染病防治的消毒產品生產;醫療器械互聯網信息服務;消毒劑生產(不含危險化學品);第一類醫療器械生產;第二類醫療器械銷售;進出口代理。

投資目的:公司投資設立深圳可孚主要是利用深圳完善的產業鏈資源優勢、人才優勢開展連續血糖監測系統等產品的創新研發和生產,以及利用粵港澳大灣區的區位優勢、政策優勢、資源優勢開展國際貿易業務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account